Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression

BACKGROUND: There is an acute need to uncover biomarkers that reflect the molecular pathologies, underpinning prostate cancer progression and poor patient outcome. We have previously demonstrated that in prostate cancer cell lines PDE4D7 is downregulated in advanced cases of the disease. To investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Böttcher, R, Henderson, D J P, Dulla, K, van Strijp, D, Waanders, L F, Tevz, G, Lehman, M L, Merkle, D, van Leenders, G J L H, Baillie, G S, Jenster, G, Houslay, M D, Hoffmann, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815894/
https://www.ncbi.nlm.nih.gov/pubmed/26575822
http://dx.doi.org/10.1038/bjc.2015.335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815894/
https://www.ncbi.nlm.nih.gov/pubmed/26575822
http://dx.doi.org/10.1038/bjc.2015.335

Ejemplares similares